Aminex Therapeutics' Series B Round

Aminex Therapeutics raised a round of funding on June 01, 2018.

Aminex Therapeutics is a drug development company focused on discovery, development, and commercialization of a new subclass of cancer immunotherapies known as suppressor cell modulators (SCMs). Ami…

Articles about Aminex Therapeutics' Series B Round: